NeuroSense Therapeutics (NRSN) Market Capitalization (2021 - 2026)
NeuroSense Therapeutics' Market Capitalization came in at $917,328 for Q2 2026, down 47.8% from $1.76 million a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Market Capitalization (2021 - 2026) Analysis & Trends
For FY2025, NeuroSense Therapeutics' Market Capitalization was $979,758, down 12.2% from FY2024.
- Market Capitalization carries a four-year compound annual growth rate of 6.3% (FY2021 to FY2025).
- Going back by year, Market Capitalization was $1.12 million in FY2024 (+84.9%), $603,627 in FY2023 (-16.0%), $718,700 in FY2022 (-6.4%) and $767,941 in FY2021.
- The Q2 2026 figure represents the lowest quarterly Market Capitalization since Q2 2024.
- Year-over-year, Market Capitalization increased in three of the last five quarters, with growth averaging 52.5%.
- The fastest year-over-year change in Market Capitalization over five years came in Q3 2024 (growth of 133.5%), and the weakest in Q2 2026 (a decline of 47.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | NeuroSense Therapeutics | 3.19 Mn | -1.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.25 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 976,569.03 |
| Jun 30, 2024 | 861,226.24 |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 603,627.34 |
| Sep 30, 2023 | 418,259.57 |
| Jun 30, 2023 | 877,756.03 |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 718,699.58 |
| Sep 30, 2022 | 979,446.81 |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | 2.17 Mn |
| Dec 31, 2021 | 1.35 Mn |
API Access
NeuroSense Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();